Hepatitis C is a contamination that for the most part influences the liver. The hepatitis C infection (HCV) causes this sickness. Frequently, a man with Hepatitis C does not have any indications (medical issues or signs that he has the ailment). In any case, ceaseless contamination can scar the liver. Numerous years of disease may bring about cirrhosis. Infrequently, individuals with cirrhosis additionally have liver disappointment or liver tumor. They can likewise have
...
Read more
Minimum Order Quantity | 3 Pack |
Packaging Size | 28 Tabs |
Strength | 90 mg and 400 mg |
Composition | Ledipasvir, Sofosbuvir |
Treatment | Hepatitis c |
Prescription/Non prescription | Prescription |
Brand | Strides |
Manufacturer | Strides |
Form | Tablet |
Shelf life | 2 Years |
Country of Origin | Made in India |
With our in-depth knowledge and rich industry experience in this field, we are highly engaged in exporting, retailing, wholesaling and supplying a qualitative VIRPAS Tablet for our esteemed clients. Processed employing advanced technology and using premium quality chemical compounds, offered tablet should only be used under proper medical guidance and advice. In order to maintain the effectiveness, our quality examiners test this tablet on various parameters.
Features:
Other Details: 28 Tablets.
Packaging Size | 28 Tabs |
Strength | 400 mg |
Composition | Sofosbuvir |
Treatment | Hepatitis c |
Prescription/Non prescription | Prescription |
Brand | Natco |
Manufacturer | Natco |
Form | Tablet |
Shelf life | 2 Years |
Country of Origin | Made in India |
Other Details: 28 Tablets.
Packaging Size | 28 tabs |
Strength | 60MG |
Composition | DACLATASVIR 60MG |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Brand | Mylan |
Manufacturer | Mylan |
Form | Tablet |
Packaging Type | 28 tablets |
Dose/Strength (ex. 1 mg or 1 ml) | 60 mg |
Other Details: 28 Tablets.
Packaging Size | 28 tabs |
Strength | 400/100 mg |
Composition | Sofosbuvir 400 mg and Velpatasvir 100 mg |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Brand | Mylan |
Manufacturer | Mylan |
Form | Tablet |
Strength/Dose (in mg or ml) | Velpatasvir 100mg and Sofosbuvir 400 mg |
Pack Size | 28 Tab |
Product Type | Finish Product |
MyHep All medication is a combination of sofosbuvir and velpatasvir. This drug work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover
MEDICINE USES :MyLan Pharmaceutical Sofosbuvir and Velpatasvir is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It may sometimes be used with another antiviral medication (ribavirin).
SOFOSBUVIR VELPATASVIR COMMON SIDE EFFECTS :Common MyHep All side effects may include:
Strength | 60MG |
Composition | DACLATASVIR 60MG |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Brand | NATCO |
Manufacturer | NATCO |
Form | Tablet |
Packaging Type | Bottle |
Dose/Strength (ex. 1 mg or 1 ml) | 60 mg |
Usage | Clinical, Hospital |
Medicine Type | Allopathic |
Packaging Size | 28 tablets |
With our in-depth knowledge and rich industry experience in this field, we are highly engaged in exporting, retailing, wholesaling and supplying a qualitative NATDAC Tablet for our esteemed clients. Processed employing advanced technology and using premium quality chemical compounds, offered tablet should only be used under proper medical guidance and advice. In order to maintain the effectiveness, our quality examiners test this tablet on various parameters.
Features:
Other Details: 28 Tablets.
Packaging Size | 28 Tabs |
Brand | Cipla |
Composition | Ledipasvir 90mg and Sofosbuvir 400mg |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Dose/Strength (ex. 1 mg or 1 ml) | 90 mg Ledipasvir and 400 mg Sofosbuvir |
Packaging Type | Bottle |
HEPCVIR L is a combination of two hepatitis C virus (HCV) antiviral drugs in a single form. Each single tablet contains ledipasvir and sofosbuvir.
USES :HEPCVIR L is a combination of ledipasvir and sofosbuvir and is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It may sometimes be used with another antiviral medication (ribavirin). These drugs work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover.
HEPCVIR L COMMON SIDE EFFECTS :Tiredness, headache, nausea, diarrhea, or difficulty sleeping may occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.
This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.
SAFETY INFORMATION (Precautions) :Packaging Size | 28 Tab |
Strength | 60 mg |
Composition | Daclatasvir |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Brand | Cipla |
Manufacturer | Hetero |
Form | Tablet |
Shelf life | 2 Years |
Country of Origin | Made in India |
Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors. It works by stopping the virus that causes hepatitis C from spreading inside the body. It is not known if daclatasvir prevents the spread of hepatitis C to other people.
How should this medicine be used?Daclatasvir comes as a tablet to take by mouth. It is usually taken with or without food once a day. Daclatasvir must be taken in combination with sofosbuvir, usually for 12 weeks. Take daclatasvir at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take daclatasvir exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Continue to take daclatasvir even if you feel well. Do not stop taking daclatasvir or sofosbuvir without talking to your doctor.
Ask your pharmacist or doctor for a copy of the manufacturer’s information for the patient.
Other uses for this medicineThis medication may be prescribed for other uses; ask your doctor or pharmacist for more information
Packaging Size | 28 tabs |
Strength | 400mg |
Composition | Sofosbuvir 400 mg |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Brand | Mylan |
Manufacturer | Mylan |
Form | Tablet |
Strength/Dose (in mg or ml) | 400 mg |
Pack Size | 28 tablets |
Product Type | Finish Product |
MOQ 28 Tab
Packaging Size | 28 tabs |
Strength | 400/100 mg |
Composition | Sofosbuvir 400 mg and Velpatasvir 100 mg |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Brand | Hetero |
Manufacturer | Hetero Labs |
Form | Tablet |
Pack Size | 28 Tab |
Dose/Strength (mg or ml) | Sofosbuvir 400 mg & velpatasvir 100 mg |
Velpatasvir Sofosbuvir ( Tab Velasof ) by Hetero is a combination of sofosbuvir and velpatasvir and is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It is also used with another antiviral medication (ribavirin). These drugs work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover.
Chronic hepatitis C infection can cause serious liver problems such as scarring (cirrhosis), or liver cancer.
Sofosbuvir 400 mg Velpatasvir 100 mg Indication :
Velasof ( Sofosbuvir 400 mg velpatasvir 100 mg) is used alone or with ribavirin to treat chronic hepatitis C. Sofosbuvir is in a class of antiviral medications called nucleotide hepatitis C virus (HCV) NS5B polymerase inhibitors. Velpatasvir is in a class of antiviral medications called HCV NS5A replication complex inhibitors.
The combination of sofosbuvir and velpatasvir works by stopping the virus that causes hepatitis C from spreading inside the body.
Packaging Size | 28 tabs |
Strength | 400/100 mg |
Composition | Sofosbuvir 400 mg and Velpatasvir 100 mg |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Brand | Zydus |
Manufacturer | Hetero Labs |
Form | Tablet |
Strength/Dose (in mg or ml) | sofosbuvir 400 mg and velpatasvir 100 mg |
Pack Size | 28 Tab |
Product Type | Finish Product |
Shelf life | 2 years |
Packaging Type | Bottles |
Country of Origin | Made in India |
Sofosbuvir With Velpatasvir is a two-drug combination for the treatment of hepatitis C. It is administered as a single daily pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir, a nucleotide inhibitor of the viral RNA polymerase. It is the first treatment, that works for all genotypic, and is taken entirely by mouth. A single tablet regimen is used for adults with genotype 1-6 chronic hepatitis C virus (HCV) infection.
Mechanism of action:Sofosbuvir With Velpatasvir is an oral fixed-dose combination of sofosbuvir, a nucleotide analog NS5B polymerase inhibitor and velapatasvir, an NS5A replication complex inhibitor. Sofosbuvir is approved for the treatment of genotype 1, 2, 3 and 4 HCV infection with different regimens and durations dependent on the HCV genotype. Velpatasvir (formerly GS-5816) is a novel NS5A inhibitor that has potent invitro anti-HCV activity across all genotypes at the picomolar level. The combination of sofosbuvir-velpatasvir is the first once-daily single-tablet regimen with pangenotypic activity.
Dosage and Administration:Sofosbuvir With Velpatasvir is available as a coformulated, once-daily single-pill combination of sofosbuvir 400 mg and velpatasvir 100 mg. The recommended dose is one tablet once daily, taken with or without food.
Risk of Serious Symptomatic Bradycardia When Sofosbuvir Is Coadministered with Amiodarone and Another HCV Direct Acting Antiviral: Amiodarone is not recommended for use with Sofosbuvir With Velpatasvir due to the risk of symptomatic bradycardia, particularly in patients also taking beta blockers or with underlying cardiac comorbidities and/or with advanced liver disease. In patients without alternative, viable treatment options, cardiac monitoring is recommended. Patients should seek immediate medical evaluation if they develop signs or symptoms of bradycardia.
Risk of Reduced Therapeutic Effect Due to Concomitant Use of Sofosbuvir With Velpatasvir with P-gp Inducers and/or Moderate to Potent Inducers of CYP2B6, CYP2C8 or CYP3A4: Rifampin, St. Johns wort, and carbamazepine are not recommended for use with Sofosbuvir With Velpatasvir as they may significantly decrease sofosbuvir and/or velpatasvir plasma concentrations.
Form | Tablet |
Dose/Strength | 60mg |
Packaging Size | 28 Tablets |
Brand | Dasikast |
Packaging Type | Bottles |
Medicine Type | Allopathic |
DESCRIPTION
Dacikast 60mg (Daclatasvir) is an inhibitor of non-structural protein 5A (NS5A). Each film-coated tablet contains Daclatasvir Dihydrochloride equivalent to Daclatasvir 30 mg or 60mg. Empirical formula for Daclatasvir Dihydrochloride is C40H50N8 O6. 2HCl. Daclatasvir is white to yellow colour solid and freely soluble in water. The tablets include the following inactive ingredients: Anhydrous Lactose, Microcrystalline cellulose, Croscarmellose sodium, Colloidal silicon dioxide, Magnesium stearate, Opadry Orange
Mechanism of Action
Dasikast Tablets Daclatasvir 60mg is an inhibitor of nonstructural protein 5A (NS5A), a multifunctional protein that is an essential component of the HCV replication complex. Daclatasvir inhibits both viral RNA replication and virion assembly.
Pharmacokinetics
The pharmacokinetic properties of Dasikast (Daclatasvir) were evaluated in healthy adult subjects and in patients with chronic HCV. Following multiple oral doses of Daclatasvir 60 mg once daily in combination with peg interferon alfa and ribavirin in treatment naive patients with genotype 1 chronic HCV, the geometric mean (CV%) Daclatasvir Cmax was 1534 (58) ng/ml, AUC0-24h was 14122 (70) ng*h/ml, and Cmin was 232 (83) ng/ml.
INDICATIONS AND USAGE
Dacikast is indicated in combination with Sofosbuvir for the treatment of patient with chronic hepatitis C virus (HCV) genotype 3 infection.
DOSAGE AND ADMINISTRATION
Treatment with Dacikast should be initiated and monitored by a physician experienced in the management of chronic hepatitis C. The recommended dose of Dacikast is 60 mg once daily, to be taken orally with or without meals. Dacikast must be administered in combination with other medicinal products. The Package Inserts of the other medicinal products in the regimen should also be consulted before initiation of therapy with Dacikast. Recommended regimens and treatment duration are provided in Table 1
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the Excipients Co-administration with medicinal products that strongly induce cytochrome P450 3A4 (CYP3A4) and P-glycoprotein transporter (P-gp) and thus may lead to lower exposure and loss of efficacy of Daclatasvir. These active substances include but are not limited to phonation, carbamazepine, oxcarbazepine, phenobarbital, rifampicin, rifabutin, rifapentine, systemic dexamethasone, and the herbal product St John’s wort (Hypericum perforatum).
OVERDOSAGE
There is limited experience of accidental overdose of Daclatasvir in clinical trials. In phase 1 clinical trials, healthy subjects who received up to 100 mg once daily for up to 14 days or single doses up to 200 mg had no unexpected adverse reactions. There is no known antidote for overdose of Daclatasvir. Treatment of overdose with Daclatasvir should consist of general supportive measures, including monitoring of vital signs, and observation of the patient’s clinical status. Because Daclatasvir is highly protein bound (99%) and has a molecular weight >500, dialysis is unlikely to significantly reduce plasma concentrations of Daclatasvir
HOW SUPPLIED AND STORAGE
Dacikast 30 mg tablets are available in bottle pack of 28 tablets. Dacikast 60 mg tablets are available in bottle pack of 28 tablets. Store below 25°C.
Dosage Form | Tablet |
Composition | Sofosbuvir 400 Mg |
Dose/Strength | 400mg |
Packaging Size | 28 tab |
Manufactured by | Strides |
With our in-depth knowledge and rich industry experience in this field, we are highly engaged in exporting, retailing, wholesaling and supplying a qualitative VIRSO Tablet for our esteemed clients. Processed employing advanced technology and using premium quality chemical compounds, offered tablet should only be used under proper medical guidance and advice. In order to maintain the effectiveness, our quality examiners test this tablet on various parameters.
Features:
Packaging Type | 28 Tablets |
Dose/Strength (ex. 1 mg or 1 ml) | 90 mg + 400 mg |
Minimum Order Quantity | 28 Piece |
Packaging Type | 28 Tablets |
Dose/Strength (ex. 1 mg or 1 ml) | 60 MG |
Other Details: 28 Tablets
Packaging Type | 28 Tablets |
With our in-depth knowledge and rich industry experience in this field, we are highly engaged in exporting, retailing, wholesaling and supplying a qualitative DACTOVIN Tablet for our esteemed clients. Processed employing advanced technology and using premium quality chemical compounds, offered tablet should only be used under proper medical guidance and advice. In order to maintain the effectiveness, our quality examiners test this tablet on various parameters.
Features:
Other Details: 28 Tablets.
Strength/Dose (in mg or ml) | 400 mg |
Pack Size | 28 Tablets |
Product Type | Finish Product |
Strength/Dose (in mg or ml) | 400 mg |
Pack Size | 28 Tablets |
Product Type | Finish Product |
Strength/Dose (in mg or ml) | 400 mg |
Pack Size | 28 Tablets |
Product Type | Finish Product |
Other Details: 7 Tablets.
Dose/Strength | ##60mg |
Dose/Strength (ex. 1 mg or 1 ml) | 60 mg |
Other Details: 28 Tablet
Packaging Type | 30 Tabets |
Dose/Strength (ex. 1 mg or 1 ml) | 0.5 mg |
Strength/Dose (in mg or ml) | Sofosbuvir 400mg and Ledipasvir 90mg |
Pack Size | 28 Tablets |
Product Type | Finish Product |
Making use of industrial expertise gained over many years, we keep coming up with products meeting the exact needs of the customers. As a Supplier, we offer yet another quality product in the form of Sofocure L Tablets. The tablets on offer are manufactured using top grade raw material. These are highly effective and durable. Our tablets are quality tested to assure their hygiene and purity.
Packaging :
Benefits :
MOQ 28 Tab
Strength/Dose (in mg or ml) | Sofosbuvir 400mg and Velpatasvir 100mg |
Pack Size | 28 Tablets |
Product Type | Finish Product |
WHAT IS RESOF TOTAL?
Resof Total medication is a combination of sofosbuvir and velpatasvir. This drug work by reducing the amount of hepatitis C virus in your body, which helps your immune system fight the infection and may help your liver recover.
MEDICINE USES :
Dr. Reddy’s Laboratories Limited Sofosbuvir and Velpatasvir is used to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It may sometimes be used with another antiviral medication (ribavirin).
SOFOSBUVIR VELPATASVIR COMMON SIDE EFFECTS :
Common Resof Total side effects may include:
headache;
tired feeling;
nausea, diarrhea; or
sleep problems (insomnia).
Call your doctor at once if you have:
slow heartbeats;
weak or shallow breathing; or
low red blood cells-pale skin, weakness, rapid heart rate, trouble concentrating.
If you also take amiodarone: Seek medical help right away if you feel weak, tired, or light-headed, or if you have chest pain, shortness of breath, confusion, or memory problems.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
Brand Name : Resof Total
Active Ingredients : Sofosbuvir Velpatasvir
Marketed by : Dr. Reddy’s Laboratories Limited
Form : Tablets
Strength : Sofosbuvir 400mg and Velpatasvir 100mg
Packing : Pack of 28 Tablets
Packaging Type | 28 Tablets |
Dose/Strength (ex. 1 mg or 1 ml) | Ledipasvir (90mg) and Sofosbuvir (400mg) |
Packaging Type | 28 Tablets |
Dose/Strength (ex. 1 mg or 1 ml) | Ledipasvir 90 mg + Sofosbuvir 400 mg |
Dose/Strength | ##Sofokem L 90mg/400mg |
Uses Ledipasvir is used in the treatment of chronic hepatitis c virus (hcv) infection How it works Ledipasvir works by lowering a load of hepatitis C virus in the body and removing the virus from the blood over a period of time.Common side effects Fatigue, Headache, Nausea, Insomnia (difficulty in sleeping), Anemia Sofosbuvir(400mg)
Uses Sofosbuvir is used in the treatment of chronic hepatitis c virus (hcv) infection How it works Sofosbuvir works by lowering a load of hepatitis C virus in the body and removing the virus from the blood over a period of time.Common side effects Fatigue, Nausea, Headache, Insomnia (difficulty in sleeping), Anemia
Strength/Dose (in mg or ml) | 400 mg |
Pack Size | 28 Tablets |
Product Type | Finish Product |
Dose | 200 mg |
EMVARIN MEDICINE
Emvarin medicine contains Ribavirin 200 mg in it. It comes in the form of capsules.Emvarin medicine is manufactured by Emcure.
Product Details:
A. Name of Medicine: EmvarinB. Chemical Used: Ribavirin Capsules USP 200 mgC. Available as: CapsulesD. Strength: 200 MgE. Packing: 28 capsulesF. Manufacturing Company: EmcureWe are suppliers/exporters of Emvarin capsules from Delhi,India. Emvarin medicine is available at discount.
Attention: The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking,check with your doctor, nurse or pharmacist.Emvarin is a prescription drug and should be used under proper medical guidance and advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.
Strength/Dose (in mg or ml) | 400 mg |
Pack Size | 28 Tablets |
Product Type | Finish Product |
Minimum Order Quantity | 28 Unit |
Strength/Dose (in mg or ml) | 400 mg |
Pack Size | 28 Tablets |
Product Type | Finish Product |
Strength/Dose (in mg or ml) | 400 mg |
Pack Size | 28 Tablets |
Product Type | Finish Product |
Packaging Size | 28 tabs |
Strength | 400/90 mg |
Composition | Sofosbuvir 400 mg and Ledipasvir 90 mg |
Treatment | Hepatitis C |
Prescription/Non prescription | Prescription |
Brand | NATCO |
Manufacturer | NATCO |
Form | Tablet |
Packaging Type | 28 Tablets |
Dose/Strength (ex. 1 mg or 1 ml) | 400 mg |
With our in-depth knowledge and rich industry experience in this field, we are highly engaged in exporting, retailing, wholesaling and supplying a qualitative Hepcinat-Lp Tablet for our esteemed clients. Processed employing advanced technology and using premium quality chemical compounds, offered tablet should only be used under proper medical guidance and advice. In order to maintain the effectiveness, our quality examiners test this tablet on various parameters.
Features:
Other Details: 28 Tablets.
Composition | Sofosbuvir 400mg and ledipasvir 90 mg |
Treatment | hepatitis C |
Prescription/Non prescription | Prescription |
Brand | Hetero |
Form | Tablet |
Strength/Dose (in mg or ml) | Ledipasvir-sofosbuvir (90 mg/400 mg |
Dosage Form | Tablet |
Pack Size | 28 Tablets |
Dose/Strength | Sofosbuvir 400mg and ledipasvir 90 mg |
Product Type | Finish Product |
Packaging Type | Bottle |
Indication:
Treating chronic hepatitis C virus (HCV) infection in certain patients.
CimivirL(Ledipasvir and sofosbuvir) is a combination of 2 hepatitis C virus (HCV) antiviral agents. It reduces the amount of HCV in the body by preventing the spread of the HCV within the body.
Mechanism of action:
Ledipasvir is a potent inhibitor of HCV NS5A, a viral phosphoprotein that plays an important role in viral replication, assembly, and secretion. Sofosbuvir is a nucleotide analog inhibitor of hepatitis C virus NS5B polymerase—the key enzyme mediating HCV RNA replication. The triphosphate form of sofosbuvir (GS-461203) mimics the natural cellular uridine nucleotide and is incorporated by the HCV RNA polymerase into the elongating RNA primer strand, resulting in viral chain termination.
Dosage and Administration:
CimivirL (Ledipasvir-sofosbuvir (90 mg/400 mg)) is a fixed-dose combination tablet . The recommended dosage is one tablet once daily, with or without food.
Side effects:
Adverse events associated with the use of Sofosbuvir in combination with Ribavirin may include, but are not limited to, the following
Precaution:
Tell your doctor or dentist that you take CimivirL(ledipasvir and sofosbuvir) before you receive any medical or dental care, emergency care, or surgery.
Do not share needles, injection supplies, or items like toothbrushes or razors. Talk with your health care provider about ways to prevent the spread of HCV to others.
Store:
CimivirL (ledipasvir Sofosbuvir) room temperature away from moisture and heat
Packaging Type | 15 Tablets |
Dose/Strength (ex. 1 mg or 1 ml) | 400 mg |
Usage | Clinical |
Other Details: 15 Tablets.
Strength/Dose (in mg or ml) | 400 mg |
Pack Size | 28 Tablets |